Effects of HIV-related stigma among an early sample of patients receiving antiretroviral therapy in Botswana

William R. Wolfe, S. D. Weiser, David Bangsberg, I. Thior, J. M. Makhema, D. B. Dickinson, K. F. Mompati, R. G. Marlink

Research output: Contribution to journalArticle

68 Citations (Scopus)

Abstract

Botswana, with its estimated HIV prevalence of 37%, instituted a policy of universal access toantiretroviral therapy (ART) in 2002. Initial enrolment lagged behind expectations, with a shortfall in voluntary testing that observers have attributed to HIV-related stigma - although there are no published data on stigma among HIV-positive individuals in Botswana. We interviewed 112 patients receiving ART in 2000, finding evidence of pervasive stigma in patterns of disclosure, social sequelae, and delays in HIV testing. Ninety-four percent of patients reported keeping their HIV status secret from their community, while 69% withheld this information even from their family. Twenty-seven percent of patients said that they feared loss of employment as a result of their HIV status. Forty percent of patients reported that they delayed getting tested for HIV; of these, 51% cited fear of a positive test result as the primary reason for delay in seeking treatment, which was often due to HIV-related stigma. These findings suggest that success of large-scale national ART programmes will require initiatives targeting stigma and its social, economic and political correlates.

Original languageEnglish (US)
Pages (from-to)931-933
Number of pages3
JournalAIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV
Volume18
Issue number8
DOIs
StatePublished - Nov 1 2006
Externally publishedYes

Fingerprint

Botswana
HIV
Therapeutics
social economics
Social Stigma
Disclosure
anxiety
Fear
Economics
community
evidence

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Health(social science)
  • Health Professions(all)
  • Social Sciences (miscellaneous)

Cite this

Effects of HIV-related stigma among an early sample of patients receiving antiretroviral therapy in Botswana. / Wolfe, William R.; Weiser, S. D.; Bangsberg, David; Thior, I.; Makhema, J. M.; Dickinson, D. B.; Mompati, K. F.; Marlink, R. G.

In: AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV, Vol. 18, No. 8, 01.11.2006, p. 931-933.

Research output: Contribution to journalArticle

Wolfe, William R. ; Weiser, S. D. ; Bangsberg, David ; Thior, I. ; Makhema, J. M. ; Dickinson, D. B. ; Mompati, K. F. ; Marlink, R. G. / Effects of HIV-related stigma among an early sample of patients receiving antiretroviral therapy in Botswana. In: AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV. 2006 ; Vol. 18, No. 8. pp. 931-933.
@article{b41c93923cfe4eb88ae7c9507a8acb0f,
title = "Effects of HIV-related stigma among an early sample of patients receiving antiretroviral therapy in Botswana",
abstract = "Botswana, with its estimated HIV prevalence of 37{\%}, instituted a policy of universal access toantiretroviral therapy (ART) in 2002. Initial enrolment lagged behind expectations, with a shortfall in voluntary testing that observers have attributed to HIV-related stigma - although there are no published data on stigma among HIV-positive individuals in Botswana. We interviewed 112 patients receiving ART in 2000, finding evidence of pervasive stigma in patterns of disclosure, social sequelae, and delays in HIV testing. Ninety-four percent of patients reported keeping their HIV status secret from their community, while 69{\%} withheld this information even from their family. Twenty-seven percent of patients said that they feared loss of employment as a result of their HIV status. Forty percent of patients reported that they delayed getting tested for HIV; of these, 51{\%} cited fear of a positive test result as the primary reason for delay in seeking treatment, which was often due to HIV-related stigma. These findings suggest that success of large-scale national ART programmes will require initiatives targeting stigma and its social, economic and political correlates.",
author = "Wolfe, {William R.} and Weiser, {S. D.} and David Bangsberg and I. Thior and Makhema, {J. M.} and Dickinson, {D. B.} and Mompati, {K. F.} and Marlink, {R. G.}",
year = "2006",
month = "11",
day = "1",
doi = "10.1080/09540120500333558",
language = "English (US)",
volume = "18",
pages = "931--933",
journal = "AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV",
issn = "0954-0121",
publisher = "Routledge",
number = "8",

}

TY - JOUR

T1 - Effects of HIV-related stigma among an early sample of patients receiving antiretroviral therapy in Botswana

AU - Wolfe, William R.

AU - Weiser, S. D.

AU - Bangsberg, David

AU - Thior, I.

AU - Makhema, J. M.

AU - Dickinson, D. B.

AU - Mompati, K. F.

AU - Marlink, R. G.

PY - 2006/11/1

Y1 - 2006/11/1

N2 - Botswana, with its estimated HIV prevalence of 37%, instituted a policy of universal access toantiretroviral therapy (ART) in 2002. Initial enrolment lagged behind expectations, with a shortfall in voluntary testing that observers have attributed to HIV-related stigma - although there are no published data on stigma among HIV-positive individuals in Botswana. We interviewed 112 patients receiving ART in 2000, finding evidence of pervasive stigma in patterns of disclosure, social sequelae, and delays in HIV testing. Ninety-four percent of patients reported keeping their HIV status secret from their community, while 69% withheld this information even from their family. Twenty-seven percent of patients said that they feared loss of employment as a result of their HIV status. Forty percent of patients reported that they delayed getting tested for HIV; of these, 51% cited fear of a positive test result as the primary reason for delay in seeking treatment, which was often due to HIV-related stigma. These findings suggest that success of large-scale national ART programmes will require initiatives targeting stigma and its social, economic and political correlates.

AB - Botswana, with its estimated HIV prevalence of 37%, instituted a policy of universal access toantiretroviral therapy (ART) in 2002. Initial enrolment lagged behind expectations, with a shortfall in voluntary testing that observers have attributed to HIV-related stigma - although there are no published data on stigma among HIV-positive individuals in Botswana. We interviewed 112 patients receiving ART in 2000, finding evidence of pervasive stigma in patterns of disclosure, social sequelae, and delays in HIV testing. Ninety-four percent of patients reported keeping their HIV status secret from their community, while 69% withheld this information even from their family. Twenty-seven percent of patients said that they feared loss of employment as a result of their HIV status. Forty percent of patients reported that they delayed getting tested for HIV; of these, 51% cited fear of a positive test result as the primary reason for delay in seeking treatment, which was often due to HIV-related stigma. These findings suggest that success of large-scale national ART programmes will require initiatives targeting stigma and its social, economic and political correlates.

UR - http://www.scopus.com/inward/record.url?scp=33749482482&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33749482482&partnerID=8YFLogxK

U2 - 10.1080/09540120500333558

DO - 10.1080/09540120500333558

M3 - Article

C2 - 17012082

AN - SCOPUS:33749482482

VL - 18

SP - 931

EP - 933

JO - AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV

JF - AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV

SN - 0954-0121

IS - 8

ER -